Please assess the completion status of the following clinical trial:

Trial Title: EFFECTS OF MOXIFLOXACIN AND GEMIFLOXACIN ON BLOOD GLUCOSE AND ECG MORPHOLOGY OF EUGLYCEMICS:A CLINICAL STUDY

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SCREENING
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy volunteers having age from 20- 40 years~* Non-Diabetic~* Non-Alcoholics~* Non-Smokers~* Non-Hypertensive~Exclusion Criteria:~* Patients with QT interval prolongation in ECG~* Patients unwilling to give consent~* Patients already on antibiotic therapy for a period one to two week or above.~* Patients who are on other drugs that induces or decreases drug metabolism of quinolones.~* Pregnant female patients.~* Abuse of alcoholic beverages~* Participants who are Allergic or Hypersensitivity to the said drug~* Participants who have participated in a clinical trial within 3 months before the study period.

- Gender: MALE
- Minimum Age: 20 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Moxfloxacin Group (Type: EXPERIMENTAL): In this arm 30 healthy volunteers were selected and they were given Moxifloxacin drug.
- Gemifloxacin Group (Type: EXPERIMENTAL): In this arm 30 healthy volunteers were selected and they were given Gemifloxacin

Based on this trial design, predict the completion outcome and termination type (if applicable).